|
|
 |
|
|
|
|
|
|
| |
|
|
|
|
| Cilag |
 |
| Cilag, an acronym formed from
the initial letters of Chemical Industry Laboratory
AG, was founded in 1936 in Schaffhausen, Switzerland.
Working out of a small laboratory initially,
its founder, Dr Bernard Joos, proved to be
a creative and prolific research chemist.
By 1952 he had discovered seven new chemical
compounds and developed them into new products.
|
|
|
|
| |
 |
|
Spearheaded by an analgesic for the urinary
tract, the company expanded into Austria
and Germany and became a name in the international
pharmaceutical market.
In 1959 Cilag became a member of Johnson
& Johnson.
|
|
|
|
|
This affiliation provided access to extensive
research capabilities for the development of new
compounds and the necessary resources to market
innovative pharmaceutical products in new therapeutic
areas. Its R&D operations were integrated with
those of the R.W. Johnson Pharmaceutical Research
Institute in Raritan, US, which in turn in 2001
integrated with the Janssen Research Foundation
in Beerse, Belgium. Together they now make up
the worldwide R&D organisation Johnson
& Johnson Pharmaceutical Research & Development
(PRD).
Its R&D track record covers discoveries and developments
in the fields of biotechnology, central nervous
system, women's health, dermatology, anti-infectives,
immunology and antimycotics.
|
|
|
|
|
|
|
|
|
